From January 1, 2024 to March 31, 2024, the company has repurchased 9,701,000 shares, representing 0.51% for CNY 37.39 million. With this, the company has completed the repurchase of 37,232,540 shares, representing 1.93% for CNY 164.86 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.02 CNY | -0.74% | +1.52% | -9.46% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.46% | 1.06B | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.